Market Research Report
Global Antiretroviral Therapy Market 2017-2021
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||580013|
|Published||Content info||81 Pages
Delivery time: 1-2 business days
|Global Antiretroviral Therapy Market 2017-2021|
|Published: November 13, 2017||Content info: 81 Pages||
The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments made in R&D, and high unmet needs in the retrovirus infection treatment domain.
Technavio's analysts forecast the global antiretroviral therapy market to grow at a CAGR of 2.64% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global antiretroviral therapy market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.
The market is divided into the following segments based on geography:
Technavio's report, Global Antiretroviral Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.